Cargando…

Interim [(18)F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma

PURPOSE: In an attempt to identify biomarkers that can reliably predict long-term outcomes to immunotherapy in metastatic melanoma, we investigated the prognostic role of [(18)F]FDG PET/CT, performed at baseline and early during the course of anti-PD-1 treatment. METHODS: Twenty-five patients with s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sachpekidis, Christos, Kopp-Schneider, Annette, Pan, Leyun, Papamichail, Dimitrios, Haberkorn, Uwe, Hassel, Jessica C., Dimitrakopoulou-Strauss, Antonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113306/
https://www.ncbi.nlm.nih.gov/pubmed/33336264
http://dx.doi.org/10.1007/s00259-020-05137-7